Nexalin Technology (NASDAQ:NXL – Get Free Report) and Algorhythm (NASDAQ:RIME – Get Free Report) are both small-cap business services companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership.
Insider & Institutional Ownership
0.7% of Nexalin Technology shares are held by institutional investors. 25.3% of Nexalin Technology shares are held by insiders. Comparatively, 0.9% of Algorhythm shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Analyst Ratings
This is a breakdown of current ratings and recommmendations for Nexalin Technology and Algorhythm, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Nexalin Technology | 1 | 0 | 0 | 0 | 1.00 |
| Algorhythm | 1 | 1 | 0 | 1 | 2.33 |
Earnings & Valuation
This table compares Nexalin Technology and Algorhythm”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Nexalin Technology | $300,000.00 | 25.11 | -$8.22 million | ($0.51) | -0.72 |
| Algorhythm | $23.49 million | 0.12 | -$23.26 million | ($5.62) | -0.19 |
Nexalin Technology has higher earnings, but lower revenue than Algorhythm. Nexalin Technology is trading at a lower price-to-earnings ratio than Algorhythm, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Nexalin Technology and Algorhythm’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Nexalin Technology | -2,722.19% | -0.87% | -0.71% |
| Algorhythm | -115.03% | N/A | -194.35% |
Volatility and Risk
Nexalin Technology has a beta of 4.05, suggesting that its stock price is 305% more volatile than the S&P 500. Comparatively, Algorhythm has a beta of -0.39, suggesting that its stock price is 139% less volatile than the S&P 500.
About Nexalin Technology
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.
About Algorhythm
Algorhythm Holdings, Inc., together with its subsidiaries, engages in the development, marketing, and sale of consumer karaoke audio equipment, accessories, and musical recordings in North America, Australia, the United Kingdom, Europe, and internationally. It offers karaoke products under the Singing Machine brand; licensed karaoke microphone products under the Carpool Karaoke brand; microphone and accessories, and portable Bluetooth microphones under the Party Machine brand; music entertainment singing machines for children under the brand Singing Machine Kids; connected vehicle karaoke devices; and karaoke music subscription services for the iOS and Android platforms, as well as a web-based download store and integrated streaming services for hardware. The company primarily sells its products to retailers, including national chains, warehouse clubs, department stores, lifestyle merchants, specialty stores, and direct mail catalogs and showrooms. The company was formerly known as The Singing Machine Company, Inc. and changed its name to Algorhythm Holdings, Inc. in September 2024. Algorhythm Holdings, Inc. was incorporated in 1982 and is headquartered in Fort Lauderdale, Florida.
Receive News & Ratings for Nexalin Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nexalin Technology and related companies with MarketBeat.com's FREE daily email newsletter.
